News Releases

Anixa Biosciences Announces Partnership with ResearchDx for Launch of Cchek™ Prostate Cancer Confirmation Test

February 25, 2019

Anixa Biosciences Extends Collaborative Research Agreement with The Wistar Institute and Leading Myeloid-derived Suppressor Cell Researcher Dmitry I. Gabrilovich, M.D., Ph.D.

February 21, 2019

Anixa Biosciences to Present at Moffitt Cancer Center's Business of Biotech Conference

February 13, 2019

Anixa Biosciences Conference Call Recording Available on Company Website

January 25, 2019

Anixa Biosciences CAR-T Cancer Therapy Patent Receives Notice of Allowance

January 24, 2019

Anixa Biosciences to Hold Conference Call to Discuss Outlook for 2019

January 16, 2019

Anixa Biosciences Announces Completion of Pre-Sub Meeting with FDA for its Cchek™ Cancer Diagnostic Test

December 19, 2018

Anixa Biosciences Presents Positive Data on its Liquid Biopsy for Early Detection of Breast Cancer at AACR Conference

December 3, 2018

Anixa Biosciences To Present Cchek™ Breast Cancer Data at AACR Special Conference on Tumor Immunology and Immunotherapy

November 15, 2018

Anixa Biosciences Presents Positive Data from its Artificial Intelligence Powered Liquid Biopsy for Prostate Cancer at SITC Conference

November 12, 2018

« Previous
1
2
3
4
5
6
7
8
9
10
...13
Next »

Latest News & Events

Sep 19, 2019

Anixa Biosciences Commences Collaboration with Potomac Urology Center on Cchek™ Prostate Cancer Study

Read More...

Sep 16, 2019

Anixa Biosciences Congratulates Scientific Advisory Board Member Dr. H. Michael Shepard as a 2019 Lasker Award Honoree

Read More...

Aug 26, 2019

Anixa Biosciences to Present at Two Upcoming Investor Conferences

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.